Nautilus Biotechnolgy Inc.
NAUT | NASDAQ
$0.98
+$0.03 (+2.65%)
Sep 22, 2026, 1:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 6.47M | 6.35M | 5.71M | 3.42M | 2.84M | 2.35M |
Gross Profit | -6.47M | -6.35M | -5.71M | -3.42M | -2.84M | -2.35M |
Operating Income | -66.84M | -81.48M | -76.15M | -63.62M | -50.5M | -15.74M |
Interest Income | 7.87M | 10.78M | 12.55M | 5.82M | 329K | n/a |
Pretax Income | -59M | -70.78M | -63.68M | -57.92M | -50.32M | -15.62M |
Net Income | -59M | -70.78M | -63.68M | -57.92M | -50.32M | -15.62M |
Selling & General & Admin | 25.73M | 31M | 28.9M | 23.75M | 21.15M | 3.31M |
Research & Development | 41.11M | 50.48M | 47.25M | 36.46M | 26.51M | 10.09M |
Other Expenses | -6.47M | -6.35M | -5.71M | n/a | n/a | n/a |
Operating Expenses | 60.37M | 75.12M | 70.45M | 60.2M | 47.66M | 13.4M |
Interest Expense | n/a | n/a | n/a | 5.82M | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 66.84M | 81.48M | 76.15M | 63.62M | 50.5M | 15.74M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 126.26M | 125.43M | 124.92M | 124.59M | 84.46M | 33.07M |
Shares Outstanding (Diluted) | 126.26M | 125.43M | 124.92M | 124.59M | 84.46M | 33.07M |
EPS (Basic) | -0.47 | -0.56 | -0.51 | -0.46 | -0.60 | -0.47 |
EPS (Diluted) | -0.47 | -0.56 | -0.51 | -0.46 | -0.60 | -0.47 |
EBITDA | -52.54M | -64.43M | -61.83M | -54.51M | -47.47M | -13.27M |
EBIT | -59M | -70.78M | -63.68M | -57.92M | -50.32M | -15.62M |
Depreciation & Amortization | 6.47M | 6.35M | 1.85M | 3.42M | 2.84M | 2.35M |
Add to Watchlist
Select watchlists to add or remove NAUT